American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
20 7월 2009 - 10:00PM
PR Newswire (US)
Siemens and Disney Team Up to Raise Awareness About Childhood
Allergies and the Importance of Early Diagnosis DEERFIELD, Ill.,
July 20 /PRNewswire-FirstCall/ -- Siemens Healthcare today released
new survey results revealing that 85 percent of mothers in the
United States believe childhood allergies are a serious concern.
Yet, when asked about testing their children for allergies, the
survey shows that many mothers know little about the testing
options available. Furthermore, more than one-third were not
familiar with the accuracy of these tests, despite 93 percent
indicating that accuracy was their top concern. The survey of over
1,000 U.S. mothers is part of a Siemens health initiative to raise
awareness about this growing epidemic in America. (Logo:
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ) The
Asthma and Allergy Foundation of America states that allergic
diseases are among the country's most common, yet often overlooked,
chronic diseases. Allergy affects more than 50 million Americans
and is now the third most common chronic disease among children
under 18 years old.(1) Depending on geography and lifestyle, the
prevalence of allergies can be as high as 40 percent.(2)
Seventy-five percent of the surveyed mothers believe it is
important for children at risk of developing allergies to be tested
early. Research indicates that this is a critical step to aiding
long-term quality of life. Early identification has been shown to
facilitate prompt and effective treatment, and therefore help
prevent the progression of allergies to asthma -- a disease
associated with significant economic costs, health risks and even
morbidity and mortality.(3) "If allergies go untreated, there is a
higher probability that the child will develop additional, more
severe symptoms, including asthma," said Dr. Terrence Zipfel,
allergist and otorhinolaryngologist, East Liverpool, Ohio.
"Fortunately, the results we can obtain from a simple blood allergy
test can have a life long impact and provide lifelong benefits."
Allergy testing methods available for children include blood tests,
skin patch tests, skin injection and the skin prick/scratch test.
The survey indicated that while most U.S. moms (75 percent) know of
the skin prick/scratch test, only a half or a third of mothers are
familiar with the other options. When questioned about the factors
most important to them when testing their own children for
allergies, 93 percent of the surveyed mothers cited accuracy as
their top concern. Other important survey findings include: -- An
average of 1 in 3 mothers reported that they do not know how
accurate the various allergy test results are. -- Of those who
responded to testing accuracy, more mothers considered the blood
test "highly accurate" (31 percent) compared to the skin
prick/scratch test (28 percent), the skin injection test (26
percent), and the skin patch test (9 percent). -- The top three
sources mothers said they would consult for information about
childhood allergies and allergy testing were: A physician or other
health professional (98 percent), health/medical web sites (73
percent), and allergy organizations (39 percent). -- Overall, the
surveyed mothers gave online interactive Websites (42 percent) and
books (35 percent) the highest marks as "very helpful" to teach
their child about allergies. "The results of this survey reinforce
the need for up-to-date, easily accessible resources that can help
inform parents about the importance of early allergy diagnosis and
the testing options available," said Donal Quinn, Chief Executive
Officer, Siemens Healthcare Diagnostics. "Many parents are not
aware that there is a safe, simple and reliable third-generation
blood test to aid in the diagnosis of allergies. Siemens is
committed to allergy awareness and support for clinicians in
providing allergy education for families -- the first step in
helping children with allergies lead active lives." Medical studies
indicate that third-generation blood tests for detecting allergies
common in children, including peanuts, insect venoms, milk, foods,
dust and a host of other allergens, may have higher rates of
precision, sensitivity and in some instances safety, than other
diagnostic options.(4,5) Blood tests pose no risk of triggering a
severe reaction in the patient being tested. The reason
third-generation allergen-specific IgE assays offer improved
sensitivity and reliability is three-fold: -- They are quantitative
-- able to measure low concentrations of IgE antibodies in a small
blood sample. -- They are automated and accurate -- similar to
other blood serum diagnostic tests. -- Their test antigens are
standardized -- enabling reliable and reproducible test results.
Siemens and The Walt Disney Company Form Alliance Furthering its
commitment to raise awareness about childhood allergies, Siemens
recently announced a strategic alliance with The Walt Disney
Company. The two companies have teamed up to teach children and
parents about health issues through Disney storytelling. Mickey and
the Giant Kachoo!, a children's book featuring Disney's Mickey
Mouse, will be introduced to clinical laboratory and physician
communities at this year's American Association for Clinical
Chemistry (AACC) Annual Meeting from July 19-23 in Chicago. For
more information, please visit
http://www.siemens.com/allergy-disney. The children's book will be
available to clinical laboratories and clinicians in the United
States later this year. The Siemens Healthcare Sector is one of the
world's largest suppliers to the healthcare industry. The company
is a renowned medical solutions provider with core competence and
innovative strength in diagnostic and therapeutic technologies as
well as in knowledge engineering, including information technology
and system integration. With its laboratory diagnostics
acquisitions, Siemens Healthcare is the first integrated healthcare
company, bringing together imaging and lab diagnostics, therapy,
and healthcare information technology solutions, supplemented by
consulting and support services. Siemens Healthcare delivers
solutions across the entire continuum of care - from prevention and
early detection, to diagnosis, therapy and care. Additionally,
Siemens Healthcare is the global market leader in innovative
hearing instruments. The company employs around 49,000 people
worldwide and operates in 130 countries. In the fiscal year 2008
(Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion,
orders of euro 11.8 billion, and Sector profit of euro 1.2 billion.
Further information can be found by visiting
http://www.siemens.com/healthcare. About the Survey: In an attempt
to gauge perceptions about childhood allergies and allergy testing,
this survey was conducted among a sample of 1,003 mothers in the
United States who have children ages 18 and under living in their
household. The survey was fielded from June 25-26, 2009 using an
online panel from eRewards. Efforts were made to collect a sample
distribution that is representative of the population in each of
the four U.S. Census regions. Participants answered questions based
upon their current level of knowledge and perception of allergies
and testing today. The survey is part of Siemens' ongoing campaign
to educate parents about ways to better screen, diagnose and manage
allergies. References: (1) "Chronic Conditions: A Challenge for the
21st Century," National Academy on an Aging Society, 2000. From the
Asthma and Allergy Foundation of America. Allergy Facts and
Figures. Web site accessed May 1, 2009:
http://www.aafa.org/display.cfm?id=9&sub=30 (2) World Allergy
Organization. Allergic Diseases Resource Center. Web site accessed
May 26, 2009:
http://www.worldallergy.org/public/allergic_diseases_center/overview.php
(3) Clinical Laboratory International. "Allergy: early, accurate
diagnosis as a basis for effective treatment." Web site accessed
July 1, 2009: http://www.cli-online.com/index.php?id=767 (4)
Biagini R, MacKenzie B, Sammons B, Smith J, Krieg E, Robertson S,
Hamilton, R. Latex specific IgE: performance characteristics of the
IMMULITE 2000 3gAllergy assay compared with skin testing. Ann
Allergy Asthma and Immunol. 2006;97:196-202. (5) "Allergy Testing
for Children," Asthma and Allergy Foundation for America Editorial
Board, 2005. Asthma and Allergy Foundation for America. Website
accessed July 15, 2009:
http://www.aafa.org/display.cfm?id=9&sub=19&cont=253
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGODATASOURCE:
Siemens Healthcare CONTACT: Media Relations, Lance Longwell,
+1-610-448-1473, , Siemens AG, Healthcare Sector -- Diagnostics
Division Web Site: http://www.siemens.com/healthcare
Copyright